SCHEMBL9122702

SCHEMBL9122702

[CH2]C(O)CN1CCN(Cc2ccccc2)CC1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.68
▸ SIGMAR1 Q99720 4/20 0.64
▸ IGF1R P08069 1/20 0.59
▸ LMNA P02545 2/20 0.57
▸ HTT P42858 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ MC4R P32245 1/20 0.55
▸ DRD4 P21917 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ PHGDH O43175 1/20 0.51
▸ MGLL Q99685 1/20 0.51
▸ HDAC4 P56524 1/20 0.51
▸ KCNH2 Q12809 1/20 0.51
▸ HDAC1 Q13547 1/20 0.51
▸ ATM Q13315 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27655710 0.84 CACNA1G (0.60) KDM4ESIGMAR1LMNAHTTGAA
SCHEMBL21797152 0.82 KDM4E (0.68) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL1394539 0.82 KDM4E (0.68) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL1394535 0.82 KDM4E (0.68) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL1394677 0.82 KDM4E (0.68) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL24672242 0.82 KDM4E (0.68) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL27360918 0.82 SIGMAR1 (0.64) KDM4ESIGMAR1IGF1RLMNAGAA
SCHEMBL4468044 0.81 KDM4E (1.00) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL29201748 0.81 KDM4E (0.66) KDM4ESIGMAR1IGF1RLMNAHTT
SCHEMBL7269243 0.81 KDM4E (0.66) KDM4ESIGMAR1IGF1RLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5476848-A Antihistamines SANKYO COMPANY, LIMITED (JP) 1995-12-19 — — US disclosed
US-5461051-A Tetracyclic compounds having anti-allergic and anti-asthmatic activities and their use SANKYO COMPANY, LIMITED (JP) 1995-10-24 — — US disclosed
US-5362725-A Antiallergens, antiasthmatic SANKYO COMPANY, LIMITED (JP) 1994-11-08 — — US disclosed
EP-0505014-A2 Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use Sankyo Company Limited (JP) 1992-09-23 — — EP disclosed
EP-0421823-A2 Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use Sankyo Company Limited (JP) 1991-04-10 — — EP disclosed
Send feedback